Silence Therapeutics (SLN) Assets (2023 - 2025)
Historic Assets for Silence Therapeutics (SLN) over the last 7 years, with Q3 2025 value amounting to $146.8 million.
- Silence Therapeutics' Assets fell 3330.13% to $146.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $146.8 million, marking a year-over-year decrease of 8212.49%. This contributed to the annual value of $202.6 million for FY2024, which is 6964.29% up from last year.
- Per Silence Therapeutics' latest filing, its Assets stood at $146.8 million for Q3 2025, which was down 3330.13% from $165.2 million recorded in Q2 2025.
- In the past 5 years, Silence Therapeutics' Assets ranged from a high of $246.6 million in Q1 2024 and a low of $105.0 million during Q2 2022
- Moreover, its 5-year median value for Assets was $140.8 million (2021), whereas its average is $155.3 million.
- Per our database at Business Quant, Silence Therapeutics' Assets surged by 11503.32% in 2024 and then tumbled by 3330.13% in 2025.
- Quarter analysis of 5 years shows Silence Therapeutics' Assets stood at $129.7 million in 2021, then decreased by 2.76% to $126.1 million in 2022, then fell by 7.65% to $116.4 million in 2023, then surged by 74.01% to $202.6 million in 2024, then fell by 27.56% to $146.8 million in 2025.
- Its last three reported values are $146.8 million in Q3 2025, $165.2 million for Q2 2025, and $185.3 million during Q1 2025.